Posted by Michael Wonder on 25 Aug 2021
Vertex Pharma gets approval for cystic fibrosis drug for infants in Canada
25 August 2021 - Vertex Pharmaceuticals was given approval to market its drug ivacaftor that treats children as young as four months of age with cystic fibrosis in Canada.
The drug is now approved for additional eligible patients in Canada, Vertex said.
